Nivolumab (Optivo), Pembrolizumab are both PD-1 inhibitors. PD-1 is a checkpoint protein on immune cells that alerts them not to attack cells that express PD-L1. Some cancer cells express PD-L1, which enables them to ''switch off an immune system respon
Clonality:
Monoclonal
Isotype:
IgG4
Purity:
Purified from cell culture supernatant by affinity chromatography
Application Dilute:
ELISA 1:5000-10000, FACS 1:100
* VAT and and shipping costs not included. Errors and price changes excepted